Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Roeder Insider Profile
4 Followers
Douglas Roeder, Director, Ten Percent Owner at Trivascular Technologies, holds 10.12M shares in Senseonics Holdings (Ticker: SENS), holds 9.67K shares in Tandem Diabetes Care (Ticker: TNDM), holds 0.00 shares in Trivascular Technologies (Ticker: TRIV).
Douglas Roeder Trivascular Technologies (TRIV)Director, Ten Percent Owner
Trivascular Technologies (TRIV)
Director, Ten Percent Owner
Ranked #2,610 out of 78,624 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+243.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Douglas Roeder holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 13, 2018 - Feb 13, 2019
Return:+800.00%
The most profitable trade made by Douglas Roeder
Douglas Roeder's Trading History
Trivascular Technologies
Feb 04, 2016
―
Uninformative Sell
―
$0.00
Senseonics Holdings
Jul 22, 2020
Director
Uninformative Buy
―
$3.72M
Tandem Diabetes Care
Aug 29, 2019
Director
Uninformative Sell
21.68M
$877.55K
List of latest transactions for each holding click on a transaction to see Douglas Roeder's performance on stock
You May Also Like
Douglas Roeder insider profile FAQ
What is the percentage of profitable transactions made by Douglas Roeder?
The percentage of profitable transactions made by Douglas Roeder is 33%.
What is the average return per transaction made by Douglas Roeder?
The average return per transaction made by Douglas Roeder is 243.00%.
What stocks does Douglas Roeder hold?
Douglas Roeder holds: TRIV, SENS, TNDM stocks.
What was Douglas Roeder’s latest transaction?
Douglas Roeder latest transaction was an Uninformative Buy of ―.
What was Douglas Roeder's most profitable transaction?
Douglas Roeder’s most profitable transaction was an Informative Buy of TNDM stock on February 13, 2018. The return on the trade was 800.00%.
What is Douglas Roeder's role in Trivascular Technologies?
Douglas Roeder's role in Trivascular Technologies is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.